Clinical Trial Update: SGLT2 Inhibitor Utilization Re-perfusion Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examines using SGLT2 inhibitors in re-perfusion therapy for acute ischemic stroke due to large vessel occlusion; the study is NO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Acute Ischemic Stroke From Large Vessel Occlusion | Phase 4 | Status: NOT_YET_RECRUITING